Clinical Trials Logo

Left Ventricular Dysfunction clinical trials

View clinical trials related to Left Ventricular Dysfunction.

Filter by:

NCT ID: NCT03659851 Recruiting - Clinical trials for Left Ventricular Dysfunction

Levosimendan In Patients Undergoing LVAD Implantation

Start date: June 1, 2009
Phase:
Study type: Observational [Patient Registry]

According to the results from the literature, it has been shown that levosimendan usage 24-48 hours before LVAD implementation can improve short and long-term outcome in these patients regarding to the patients without preoperative pretreatment. The aim is to compare short and long-term outcome in patients who underwent to LVAD implementation and pretreated with levosimendan regarding the patient without pretreatment or with other medications.

NCT ID: NCT01267331 Recruiting - Clinical trials for Left Ventricular Dysfunction

Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery

Start date: December 2010
Phase: Phase 1/Phase 2
Study type: Interventional

This prospective, randomized, placebo-controlled study was designed to assess the safety, feasibility and efficacy of intramyocardial injection of autologous bone marrow mononuclear cells in patients with severe, chronic ischemic disease scheduled to coronary artery bypass surgery.

NCT ID: NCT00512005 Recruiting - Heart Failure Clinical Trials

VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study

VIVID
Start date: January 2008
Phase: Phase 1
Study type: Interventional

The purpose of this prospective, non-randomized, single-arm feasibility study is to evaluate safety and feasibility of the iCoapsys System in patients with functional mitral valve insufficiency caused by annular dilation and/or papillary muscle displacement.

NCT ID: NCT00188994 Recruiting - Clinical trials for Left Ventricular Dysfunction

Insulin Cardioplegia for Poor Left Ventricular Function

Start date: August 1999
Phase: N/A
Study type: Interventional

The purpose of this investigation is to develop a means to improve the recovery of cardiac metabolism and ventricular function following coronary artery bypass surgery (CABG) in patients with poor preoperative ventricular function (e.g. ejection fraction <40%).